Management of Sinusitis Not Responding to Amoxicillin-Clavulanate

Initial Assessment and Treatment

The American Academy of Allergy, Asthma, and Immunology recommends switching to a respiratory fluoroquinolone, such as levofloxacin 500 mg once daily or moxifloxacin 400 mg once daily, for 5-10 days, as these agents provide 90-92% predicted clinical efficacy against resistant pathogens, including penicillin-resistant S. pneumoniae and beta-lactamase-producing H. influenzae, in patients with sinusitis not responding to amoxicillin-clavulanate 1, 2
When sinusitis fails to respond to amoxicillin-clavulanate, the American College of Allergy, Asthma, and Immunology suggests determining the degree of response, with poor response requiring immediate antibiotic change, and partial response potentially warranting either continuing treatment or switching antibiotics, in order to guide further management 3

The Infectious Diseases Society of America recommends respiratory fluoroquinolones as the preferred next step in treatment due to recent antibiotic exposure being a major risk factor for harboring resistant organisms, necessitating a different antibiotic class, in patients with sinusitis not responding to initial therapy 2
Moxifloxacin 400 mg once daily for 5-10 days is a recommended regimen, with 99% activity against S. pneumoniae and 95-100% activity against H. influenzae, providing superior coverage compared to other oral options for resistant pathogens, according to the American Academy of Otolaryngology 1, 2

The American Academy of Family Physicians suggests considering cephalosporins, such as cefuroxime, cefpodoxime, or cefdinir, for 10-14 days, which provide adequate coverage for S. pneumoniae, H. influenzae, and M. catarrhalis, in patients who cannot use fluoroquinolones 3, 1
Parenteral ceftriaxone, 1 gram IM or IV daily for 5 days, ensures adequate tissue concentrations and is a recommended alternative, according to the Infectious Diseases Society of America 2

The American Academy of Allergy, Asthma, and Immunology recommends adding intranasal corticosteroids, particularly beneficial when marked mucosal edema or nasal polyposis is present, to enhance treatment success in patients with sinusitis not responding to amoxicillin-clavulanate 1, 2
Implementing supportive measures, such as saline irrigation, adequate hydration, analgesics, warm facial packs, and steamy showers, can help improve symptoms and treatment outcomes, according to the American College of Allergy, Asthma, and Immunology 1, 2, 3

The American Academy of Otolaryngology expects clinical improvement within 3-5 days of starting appropriate therapy, and if symptoms worsen after 48-72 hours or fail to improve after 3-5 days, further evaluation is needed, including consideration of obtaining cultures by direct sinus aspiration or endoscopically guided cultures if patient fails second-line therapy 1, 2, 6